首页> 外文OA文献 >PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection
【2h】

PvdQ Quorum Quenching Acylase Attenuates Pseudomonas aeruginosa Virulence in a Mouse Model of Pulmonary Infection

机译:PVDQ Quorum淬火酰化酶在肺部感染小鼠模型中衰减假单胞菌铜绿假单胞菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pseudomonas aeruginosa is the predominant pathogen in pulmonary infections associated with cystic fibrosis. Quorum sensing (QS) systems regulate the production of virulence factors and play an important role in the establishment of successful P. aeruginosa infections. Inhibition of the QS system (termed quorum quenching) renders the bacteria avirulent thus serving as an alternative approach in the development of novel antibiotics. Quorum quenching in Gram negative bacteria can be achieved by preventing the accumulation of N-acyl homoserine lactone (AHL) signaling molecule via enzymatic degradation. Previous work by us has shown that PvdQ acylase hydrolyzes AHL signaling molecules irreversibly, thereby inhibiting QS in P. aeruginosa in vitro and in a Caenorhabditis elegans model of P. aeruginosa infection. The aim of the present study is to assess the therapeutic efficacy of intranasally instilled PvdQ acylase in a mouse model of pulmonary P. aeruginosa infection. First, we evaluated the deposition pattern of intranasally administered fluorochrome-tagged PvdQ (PvdQ-VT) in mice at different stages of pulmonary infection by in vivo imaging studies. Following intranasal instillation, PvdQ-VT could be traced in all lung lobes with 42 ± 7.5% of the delivered dose being deposited at 0 h post-bacterial-infection, and 34 ± 5.2% at 72 h post bacterial-infection. We then treated mice with PvdQ during lethal P. aeruginosa pulmonary infection and that resulted in a 5-fold reduction of lung bacterial load and a prolonged survival of the infected animals with the median survival time of 57 hin comparison to 42 h for the PBS-treated group. In a sublethal P. aeruginosa pulmonary infection, PvdQ treatment resulted in less lung inflammation as well as decrease of CXCL2 and TNF-α levels at 24 h post-bacterial-infection by 15 and 20%, respectively. In conclusion, our study has shown therapeutic efficacy of PvdQ acylase as a quorum quenching agent during P. aeruginosa infection.
机译:绿脓杆菌是囊性纤维化相关的肺部感染的主要病原体。群体感应(QS)制度规范生产的毒力因子,并发挥在建立成功的铜绿假单胞菌感染的重要作用。的QS系统(称为群体淬灭)的抑制使得由此细菌无毒力用作在新型抗生素的发展的另一种方法。在革兰氏阴性细菌群体淬灭可以通过防止N-酰基高丝氨酸内酯(AHL)信号传导分子通过酶降解的积累来实现。通过我们以前的工作已经表明,PvdQ酰基转移酶水解AHL信号分子不可逆,从而抑制QS铜绿假单胞菌在体外和P的秀丽隐杆线虫模型假单胞菌感染。本研究的目的是评估肺绿脓假单胞菌感染的小鼠模型中鼻内滴注PvdQ酰基转移酶的治疗功效。首先,我们评估了鼻内施用的沉积图案的荧光染料标记的在肺部感染的不同阶段的小鼠PvdQ(PvdQ-VT)通过体内成像研究。以下鼻内滴注,PvdQ-VT可在所有肺叶被追踪与递送的剂量在0 H-细菌感染后沉积的42±7.5%,并且在72小时后的细菌感染34±5.2%。然后,我们致死P.期间处理的小鼠与PvdQ假单胞菌肺部感染和,导致肺部细菌负载的5倍的减少和感染的动物与57的中位存活时间延长了存活欣比较42h中的PBS-治疗组。在亚致死铜绿假单胞菌肺部感染,治疗PvdQ分别导致更少肺部炎症,以及在24小时后的细菌感染和CXCL2 TNF-α水平的降低了15和20%。总之,我们的研究已经显示出PvdQ的治疗功效的铜绿假单胞菌感染期间酰基转移酶为法定猝灭剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号